Risk factors of long COVID among discharged patients with omicron infection in Changzhi, China: a retrospective cohort study
Authors:
Open Access
- 12 August 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1774108
Abstract
Background: Relatively little is known about long COVID (LC) in China, particularly regarding the effects of recent Omicron sub-lineages. Therefore, we systematically assessed the prevalence and risk factors for developing LC. Methods: This retrospective cohort study included COVID-19 patients who had been hospitalized at two hospitals in Changzhi, China, between December 15, 2022 and April 30, 2024. All patients were interviewed via telephone ≥ 3 months after discharge. The follow-up study was conducted between July 18 and August 20, 2024. Logistic regression models were used to analyze risk factors for developing long COVID. Results: A total of 2,765 patients (1,407 male [50.9%]; median [IQR] age 70.0 [59.0–78.0] years) were successfully evaluated by telephone; 458 (16.6%) self-reported long COVID symptoms. The most common symptom was fatigue (4.9%), followed by muscle weakness (3.9%), sleep difficulties (3.0%), brain fog (2.8%) and cough (2.5%). Severe COVID-19 patients had a higher risk of LC than non-severe patients (OR = 1.275, 95% CI: 1.036–1.570). In subgroup analyses stratified by follow-up time, overweight patients (OR = 1.564; 95% CI: 1.052–2.326), patients with ≥ 7 acute-phase symptoms (OR = 1.275; 95% CI: 1.064–1.528), and farmer (OR = 1.439, 95% CI: 1.047, 1.976) had a higher risk of LC, whereas individuals who received immunosuppressant therapy had a lower risk (OR = 0.691, 95% CI: 0.504, 0.948). In addition, aged ≥ 50 years (OR = 2.441, 95% CI: 1.175–5.072) and underweight status (OR = 2.183; 95% CI: 1.115–4.273) were associated with a higher risk of muscle weakness. Conclusion: This study provides valuable insights into LC after discharge, with 16.6% of discharged patients reporting symptoms. It is essential to monitor at-risk individuals according to identified risk factors for public health efforts.Keywords
This publication has 49 references indexed in Scilit:
- Clinical features and predictive nomogram for fatigue sequelae in non-severe patients infected with SARS-CoV-2 Omicron variant in Shanghai, ChinaBrain, Behavior, & Immunity - Health, 2024
- The efficacy of antivirals, corticosteroids, and monoclonal antibodies as acute COVID-19 treatments in reducing the incidence of long COVID: a systematic review and meta-analysisClinical Microbiology and Infection, 2024
- Decreased risk of COVID-19 and long COVID in patients with psoriasis receiving IL-23 inhibitor: A cross-sectional cohort study from ChinaHeliyon, 2024
- Prevalence and risk factors of long COVID 6–12 months after infection with the Omicron variant among nonhospitalized patients in Hong KongJournal of Medical Virology, 2023
- Prevalence and clinical presentation of long COVID in children: a systematic reviewEuropean Journal of Pediatrics, 2022
- Two-Year Health Outcomes in Hospitalized COVID-19 Survivors in ChinaJAMA Network Open, 2022
- Symptoms and Health Outcomes Among Survivors of COVID-19 Infection 1 Year After Discharge From Hospitals in Wuhan, ChinaJAMA Network Open, 2021
- Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19JAMA Network Open, 2021
- Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal studyClinical Microbiology and Infection, 2021
- Persistent Symptoms in Patients After Acute COVID-19JAMA, 2020